A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections
Condition:   Hypogonadism, Male Interventions:   Drug: Testosterone Cypionate 200 MG/ML;   Drug: Intranasal Testosterone Sponsors:   University of Miami;   Acerus Pharmaceuticals Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2020 Category: Research Source Type: clinical trials